Safety & Immunogenicity of an Alternative Immunization Schedule of GSK Bio's Pandemic Influenza Vaccine (GSK1119711A)

NCT00430521 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

512

Enrollment

INDUSTRY

Sponsor class

Conditions

Influenza
Influenza Vaccines

Interventions

BIOLOGICAL: Pandemic influenza vaccine (GSK1119711A)-formulation 1
BIOLOGICAL: Pandemic influenza vaccine (GSK1119711A)-formulation 2

Sponsor

GlaxoSmithKline